We then asked whether somatic mutations in TBX3 are present in humans with MASLD (Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/JCI191855DS1). This evidence concerns the gene TBX3 and metabolic dysfunction-associated steatotic liver disease.